Caricamento...
Protective effect of tolvaptan against cyclophosphamide‐induced nephrotoxicity in rat models
Cyclophosphamide (CP) is a chemotherapeutic agent which is extensively used in the treatment of multiple neoplastic and nonneoplastic diseases like breast cancer, lymphomas, systemic lupus erythematosus, and multiple sclerosis. Dose‐limiting side effects, mainly nephrotoxicity is a major problem hin...
Salvato in:
| Pubblicato in: | Pharmacol Res Perspect |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
John Wiley and Sons Inc.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7525803/ https://ncbi.nlm.nih.gov/pubmed/32996719 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.659 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|